Menu
Back to Journals » Vascular Health and Risk Management » Volume 12
Review
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 24,602 | Dovepress* | 6,374 | 3,624+ | 2,556 | 9,998 |
| PubMed Central* | 0 | 14,604 | 2,103 | 14,604 | |
| Totals | 6,374 | 18,228 | 4,659 | 24,602 | |
|
*Since 4 June 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 2 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar